HomeCompareNPKYY vs EQR

NPKYY vs EQR: Dividend Comparison 2026

NPKYY yields 3.96% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPKYY wins by $395.4K in total portfolio value· pulled ahead in Year 2
10 years
NPKYY
NPKYY
● Live price
3.96%
Share price
$11.38
Annual div
$0.45
5Y div CAGR
50.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$443.1K
Annual income
$243,801.89
Full NPKYY calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — NPKYY vs EQR

📍 NPKYY pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPKYYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPKYY + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPKYY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPKYY
Annual income on $10K today (after 15% tax)
$336.26/yr
After 10yr DRIP, annual income (after tax)
$207,231.61/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, NPKYY beats the other by $202,577.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPKYY + EQR for your $10,000?

NPKYY: 50%EQR: 50%
100% EQR50/50100% NPKYY
Portfolio after 10yr
$245.5K
Annual income
$124,638.74/yr
Blended yield
50.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

NPKYY
No analyst data
Altman Z
3.2
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPKYY buys
0
EQR buys
0
No recent congressional trades found for NPKYY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPKYYEQR
Forward yield3.96%5.87%
Annual dividend / share$0.45$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.8%15.8%
Portfolio after 10y$443.1K$47.8K
Annual income after 10y$243,801.89$5,475.61
Total dividends collected$400.8K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NPKYY vs EQR ($10,000, DRIP)

YearNPKYY PortfolioNPKYY Income/yrEQR PortfolioEQR Income/yrGap
1$11,297$596.57$11,380$679.82$83.00EQR
2← crossover$13,037$949.79$13,014$837.25+$23.00NPKYY
3$15,495$1,544.82$14,961$1,036.20+$534.00NPKYY
4$19,167$2,587.58$17,297$1,289.22+$1.9KNPKYY
5$25,019$4,511.08$20,121$1,613.15+$4.9KNPKYY
6$35,070$8,299.06$23,561$2,030.84+$11.5KNPKYY
7$53,919$16,394.67$27,783$2,573.54+$26.1KNPKYY
8$93,219$35,524.76$33,013$3,284.39+$60.2KNPKYY
9$186,302$86,557.67$39,547$4,223.51+$146.8KNPKYY
10$443,145$243,801.89$47,791$5,475.61+$395.4KNPKYY

NPKYY vs EQR: Complete Analysis 2026

NPKYYStock

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.

Full NPKYY Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this NPKYY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPKYY vs SCHDNPKYY vs JEPINPKYY vs ONPKYY vs KONPKYY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.